Cite

    Li, D. et al. (2020). Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Pharmacoepidemiology and drug safety. 29 (5), pp. 582-590. [Online].